2-219220778-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_001077198.3(ATG9A):c.2483C>T(p.Ser828Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
ATG9A
NM_001077198.3 missense
NM_001077198.3 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 7.43
Genes affected
ATG9A (HGNC:22408): (autophagy related 9A) Acts upstream of or within autophagosome assembly. Located in endosome; phagophore assembly site; and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity ATG9A_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25267506).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG9A | NM_001077198.3 | c.2483C>T | p.Ser828Leu | missense_variant | 15/16 | ENST00000361242.9 | NP_001070666.1 | |
ATG9A | NM_024085.5 | c.2483C>T | p.Ser828Leu | missense_variant | 14/15 | NP_076990.4 | ||
ATG9A | NR_104255.2 | n.2607C>T | non_coding_transcript_exon_variant | 15/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG9A | ENST00000361242.9 | c.2483C>T | p.Ser828Leu | missense_variant | 15/16 | 2 | NM_001077198.3 | ENSP00000355173.4 | ||
ENSG00000284820 | ENST00000446716.5 | n.728C>T | non_coding_transcript_exon_variant | 5/22 | 2 | ENSP00000398528.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152036Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
8
AN:
152036
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248950Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135198
GnomAD3 exomes
AF:
AC:
5
AN:
248950
Hom.:
AF XY:
AC XY:
1
AN XY:
135198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461274Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 726922
GnomAD4 exome
AF:
AC:
20
AN:
1461274
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
726922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152036Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74278
GnomAD4 genome
AF:
AC:
8
AN:
152036
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
74278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.2483C>T (p.S828L) alteration is located in exon 15 (coding exon 13) of the ATG9A gene. This alteration results from a C to T substitution at nucleotide position 2483, causing the serine (S) at amino acid position 828 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;L;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;D;D;.
Vest4
MutPred
Loss of phosphorylation at S828 (P = 0.0049);Loss of phosphorylation at S828 (P = 0.0049);Loss of phosphorylation at S828 (P = 0.0049);.;
MVP
MPC
0.20
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at